ID   FAK1_HUMAN              Reviewed;        1052 AA.
AC   Q05397; Q14291; Q9UD85;
DT   01-FEB-1994, integrated into UniProtKB/Swiss-Prot.
DT   15-JUL-1998, sequence version 2.
DT   02-NOV-2010, entry version 136.
DE   RecName: Full=Focal adhesion kinase 1;
DE            Short=FADK 1;
DE            EC=2.7.10.2;
DE   AltName: Full=Protein-tyrosine kinase 2;
DE   AltName: Full=pp125FAK;
GN   Name=PTK2; Synonyms=FAK, FAK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RC   TISSUE=T-cell;
RX   MEDLINE=94030617; PubMed=7692878; DOI=10.1089/dna.1993.12.823;
RA   Whitney G.S., Chan P.Y., Blake J., Cosand W.L., Neubauer M.G.,
RA   Aruffo A., Kanner S.B.;
RT   "Human T and B lymphocytes express a structurally conserved focal
RT   adhesion kinase, pp125FAK.";
RL   DNA Cell Biol. 12:823-830(1993).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 2; 3 AND 4).
RC   TISSUE=Brain;
RX   MEDLINE=93135758; PubMed=8422239; DOI=10.1006/bbrc.1993.1022;
RA   Andre E., Becker-Andre M.;
RT   "Expression of an N-terminally truncated form of human focal adhesion
RT   kinase in brain.";
RL   Biochem. Biophys. Res. Commun. 190:140-147(1993).
RN   [3]
RP   PROTEIN SEQUENCE OF 2-19; 192-199; 222-236; 243-252; 350-364; 414-419;
RP   468-476; 562-569; 674-690; 798-811; 832-838; 904-933; 963-981;
RP   989-1000 AND 1003-1042, CLEAVAGE OF INITIATOR METHIONINE, ACETYLATION
RP   AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Osteosarcoma;
RA   Bienvenut W.V., Glen H., Brunton V.G., Frame M.C.;
RL   Submitted (JUL-2007) to UniProtKB.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 552-602, AND TISSUE SPECIFICITY.
RC   TISSUE=Melanocyte;
RX   MEDLINE=94067791; PubMed=8247543;
RA   Lee S.-T., Strunk K.M., Spritz R.A.;
RT   "A survey of protein tyrosine kinase mRNAs expressed in normal human
RT   melanocytes.";
RL   Oncogene 8:3403-3410(1993).
RN   [5]
RP   INTERACTION WITH TGFB1I1.
RX   MEDLINE=98086276; PubMed=9422762; DOI=10.1074/jbc.273.2.1003;
RA   Matsuya M., Sasaki H., Aoto H., Mitaka T., Nagura K., Ohba T.,
RA   Ishino M., Takahashi S., Suzuki R., Sasaki T.;
RT   "Cell adhesion kinase beta forms a complex with a new member, Hic-5,
RT   of proteins localized at focal adhesions.";
RL   J. Biol. Chem. 273:1003-1014(1998).
RN   [6]
RP   INTERACTION WITH TGFB1I1, AND MUTAGENESIS OF VAL-928 AND LEU-1034.
RX   PubMed=9756887; DOI=10.1074/jbc.273.41.26516;
RA   Fujita H., Kamiguchi K., Cho D., Shibanuma M., Morimoto C.,
RA   Tachibana K.;
RT   "Interaction of Hic-5, A senescence-related protein, with focal
RT   adhesion kinase.";
RL   J. Biol. Chem. 273:26516-26521(1998).
RN   [7]
RP   PHOSPHORYLATION AT TYR-397; TYR-407; TYR-577; TYR-861 AND TYR-925.
RX   MEDLINE=22399531; PubMed=12387730; DOI=10.1042/BJ20020410;
RA   Relou I.A.M., Bax L.A.B., Van Rijn H.J.M., Akkerman J.-W.N.;
RT   "Site-specific phosphorylation of platelet focal adhesion kinase by
RT   low-density lipoprotein.";
RL   Biochem. J. 369:407-416(2003).
RN   [8]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=15951569; DOI=10.1074/mcp.M500089-MCP200;
RA   Zhang Y., Wolf-Yadlin A., Ross P.L., Pappin D.J., Rush J.,
RA   Lauffenburger D.A., White F.M.;
RT   "Time-resolved mass spectrometry of tyrosine phosphorylation sites in
RT   the epidermal growth factor receptor signaling network reveals dynamic
RT   modules.";
RL   Mol. Cell. Proteomics 4:1240-1250(2005).
RN   [9]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-397 AND SER-840, AND
RP   MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;
RA   Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,
RA   Mann M.;
RT   "Global, in vivo, and site-specific phosphorylation dynamics in
RT   signaling networks.";
RL   Cell 127:635-648(2006).
RN   [10]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-397; TYR-570; TYR-576;
RP   TYR-577 AND TYR-861, AND MASS SPECTROMETRY.
RC   TISSUE=Lung carcinoma;
RX   PubMed=18083107; DOI=10.1016/j.cell.2007.11.025;
RA   Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,
RA   Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,
RA   Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,
RA   Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,
RA   Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.;
RT   "Global survey of phosphotyrosine signaling identifies oncogenic
RT   kinases in lung cancer.";
RL   Cell 131:1190-1203(2007).
RN   [11]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-397; TYR-576; SER-722;
RP   SER-840; SER-843 AND SER-910, AND MASS SPECTROMETRY.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=17192257; DOI=10.1074/mcp.T600062-MCP200;
RA   Wissing J., Jaensch L., Nimtz M., Dieterich G., Hornberger R.,
RA   Keri G., Wehland J., Daub H.;
RT   "Proteomics analysis of protein kinases by target class-selective
RT   prefractionation and tandem mass spectrometry.";
RL   Mol. Cell. Proteomics 6:537-547(2007).
RN   [12]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=17389395; DOI=10.1073/pnas.0608638104;
RA   Wolf-Yadlin A., Hautaniemi S., Lauffenburger D.A., White F.M.;
RT   "Multiple reaction monitoring for robust quantitative proteomic
RT   analysis of cellular signaling networks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:5860-5865(2007).
RN   [13]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-13; SER-29; SER-568;
RP   TYR-570; SER-722; SER-840; SER-887 AND SER-910, AND MASS SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [14]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-910, AND MASS
RP   SPECTROMETRY.
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [15]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RA   Colinge J., Superti-Furga G., Bennett K.L.;
RL   Submitted (OCT-2008) to UniProtKB.
RN   [16]
RP   ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY.
RC   TISSUE=Embryonic kidney;
RX   PubMed=19413330; DOI=10.1021/ac9004309;
RA   Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,
RA   Mohammed S.;
RT   "Lys-N and trypsin cover complementary parts of the phosphoproteome in
RT   a refined SCX-based approach.";
RL   Anal. Chem. 81:4493-4501(2009).
RN   [17]
RP   INTERACTION WITH STEAP4.
RX   PubMed=19787193;
RA   Tamura T., Chiba J.;
RT   "STEAP4 regulates focal adhesion kinase activation and CpG motifs
RT   within STEAP4 promoter region are frequently methylated in DU145,
RT   human androgen-independent prostate cancer cells.";
RL   Int. J. Mol. Med. 24:599-604(2009).
RN   [18]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-576; TYR-577 AND
RP   TYR-861, AND MASS SPECTROMETRY.
RC   TISSUE=Mammary epithelium;
RX   PubMed=19534553; DOI=10.1021/pr900044c;
RA   Heibeck T.H., Ding S.-J., Opresko L.K., Zhao R., Schepmoes A.A.,
RA   Yang F., Tolmachev A.V., Monroe M.E., Camp D.G. II, Smith R.D.,
RA   Wiley H.S., Qian W.-J.;
RT   "An extensive survey of tyrosine phosphorylation revealing new sites
RT   in human mammary epithelial cells.";
RL   J. Proteome Res. 8:3852-3861(2009).
RN   [19]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-5; THR-13; SER-16;
RP   SER-29; THR-386; SER-390; SER-392; THR-394; TYR-397; THR-406; TYR-407;
RP   TYR-570; THR-575; TYR-576; TYR-577; SER-580; SER-677; THR-700;
RP   SER-702; SER-705; SER-708; SER-716; TYR-720; SER-722; SER-840;
RP   SER-843; TYR-861 AND SER-910, PHOSPHORYLATION [LARGE SCALE ANALYSIS]
RP   AT TYR-688 (ISOFORM 2), AND MASS SPECTROMETRY.
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [20]
RP   VARIANTS [LARGE SCALE ANALYSIS] PRO-292; GLN-292; ALA-793; GLU-1030
RP   AND GLU-1044.
RX   PubMed=17344846; DOI=10.1038/nature05610;
RA   Greenman C., Stephens P., Smith R., Dalgliesh G.L., Hunter C.,
RA   Bignell G., Davies H., Teague J., Butler A., Stevens C., Edkins S.,
RA   O'Meara S., Vastrik I., Schmidt E.E., Avis T., Barthorpe S.,
RA   Bhamra G., Buck G., Choudhury B., Clements J., Cole J., Dicks E.,
RA   Forbes S., Gray K., Halliday K., Harrison R., Hills K., Hinton J.,
RA   Jenkinson A., Jones D., Menzies A., Mironenko T., Perry J., Raine K.,
RA   Richardson D., Shepherd R., Small A., Tofts C., Varian J., Webb T.,
RA   West S., Widaa S., Yates A., Cahill D.P., Louis D.N., Goldstraw P.,
RA   Nicholson A.G., Brasseur F., Looijenga L., Weber B.L., Chiew Y.-E.,
RA   DeFazio A., Greaves M.F., Green A.R., Campbell P., Birney E.,
RA   Easton D.F., Chenevix-Trench G., Tan M.-H., Khoo S.K., Teh B.T.,
RA   Yuen S.T., Leung S.Y., Wooster R., Futreal P.A., Stratton M.R.;
RT   "Patterns of somatic mutation in human cancer genomes.";
RL   Nature 446:153-158(2007).
CC   -!- FUNCTION: Non-receptor protein-tyrosine kinase implicated in
CC       signaling pathways involved in cell motility, proliferation and
CC       apoptosis. Activated by tyrosine-phosphorylation in response to
CC       either integrin clustering induced by cell adhesion or antibody
CC       cross-linking, or via G-protein coupled receptor (GPCR) occupancy
CC       by ligands such as bombesin or lysophosphatidic acid, or via LDL
CC       receptor occupancy. Plays a potential role in oncogenic
CC       transformations resulting in increased kinase activity.
CC   -!- CATALYTIC ACTIVITY: ATP + a [protein]-L-tyrosine = ADP + a
CC       [protein]-L-tyrosine phosphate.
CC   -!- SUBUNIT: Interacts with CAS family members and with GIT1, SORBS1
CC       and BCAR3. Interacts with RGNEF and SHB (By similarity). Interacts
CC       with TGFB1I1 and STEAP4.
CC   -!- INTERACTION:
CC       P49023:PXN; NbExp=2; IntAct=EBI-702142, EBI-702209;
CC       Q7L0Q8:RHOU; NbExp=1; IntAct=EBI-702142, EBI-1638043;
CC       P12931:SRC; NbExp=2; IntAct=EBI-702142, EBI-621482;
CC       O43294:TGFB1I1; NbExp=1; IntAct=EBI-702142, EBI-1051449;
CC       Q62219:Tgfb1i1 (xeno); NbExp=2; IntAct=EBI-702142, EBI-642844;
CC       Q68CZ2:TNS3; NbExp=1; IntAct=EBI-702142, EBI-1220488;
CC       P04637:TP53; NbExp=6; IntAct=EBI-702142, EBI-366083;
CC   -!- SUBCELLULAR LOCATION: Cell junction, focal adhesion. Cell
CC       membrane; Peripheral membrane protein; Cytoplasmic side.
CC       Note=Constituent of focal adhesions.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q05397-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q05397-2; Sequence=VSP_004967, VSP_004968, VSP_004969,
CC                                  VSP_004970;
CC         Note=Phosphorylated on Tyr-688;
CC       Name=3;
CC         IsoId=Q05397-3; Sequence=VSP_004967, VSP_004968, VSP_004969,
CC                                  VSP_004973, VSP_004974;
CC       Name=4;
CC         IsoId=Q05397-4; Sequence=VSP_004967, VSP_004968, VSP_004969,
CC                                  VSP_004971, VSP_004972;
CC   -!- TISSUE SPECIFICITY: Expressed in all organs tested, in lymphoid
CC       cell lines, but most abundantly in brain.
CC   -!- DOMAIN: The first Pro-rich domain interacts with the SH3 domain of
CC       CRK-associated substrate (BCAR1) and CASL (By similarity).
CC   -!- DOMAIN: The carboxy-terminal region is the site of focal adhesion
CC       targeting (FAT) sequence which mediates the localization of FAK1
CC       to focal adhesions.
CC   -!- PTM: Phosphorylated on 6 tyrosine residues upon activation.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. Tyr protein
CC       kinase family. FAK subfamily.
CC   -!- SIMILARITY: Contains 1 FERM domain.
CC   -!- SIMILARITY: Contains 1 protein kinase domain.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; L13616; AAA58469.1; -; mRNA.
DR   EMBL; L05186; AAA35819.1; -; mRNA.
DR   IPI; IPI00012885; -.
DR   IPI; IPI00216217; -.
DR   IPI; IPI00216218; -.
DR   IPI; IPI00871963; -.
DR   PIR; I53012; I53012.
DR   PIR; PC1225; PC1225.
DR   RefSeq; NP_005598.3; -.
DR   RefSeq; NP_722560.1; -.
DR   UniGene; Hs.395482; -.
DR   PDB; 1K04; X-ray; 1.95 A; A=891-1052.
DR   PDB; 1K05; X-ray; 2.90 A; A/B/C=891-1052.
DR   PDB; 1MP8; X-ray; 1.60 A; A=411-686.
DR   PDB; 1OW6; X-ray; 2.35 A; A/B/C=892-1052.
DR   PDB; 1OW7; X-ray; 2.60 A; A/B/C=892-1052.
DR   PDB; 1OW8; X-ray; 2.85 A; A/B/C=892-1052.
DR   PDB; 2ETM; X-ray; 2.30 A; A/B=411-689.
DR   PDB; 2IJM; X-ray; 2.19 A; A/B=411-689.
DR   PDB; 2RA7; X-ray; 1.99 A; A=921-1048.
DR   PDB; 3B71; X-ray; 2.82 A; A/B/C=891-1052.
DR   PDB; 3BZ3; X-ray; 2.20 A; A=414-689.
DR   PDBsum; 1K04; -.
DR   PDBsum; 1K05; -.
DR   PDBsum; 1MP8; -.
DR   PDBsum; 1OW6; -.
DR   PDBsum; 1OW7; -.
DR   PDBsum; 1OW8; -.
DR   PDBsum; 2ETM; -.
DR   PDBsum; 2IJM; -.
DR   PDBsum; 2RA7; -.
DR   PDBsum; 3B71; -.
DR   PDBsum; 3BZ3; -.
DR   ProteinModelPortal; Q05397; -.
DR   SMR; Q05397; 33-363, 35-686.
DR   IntAct; Q05397; 35.
DR   MINT; MINT-92695; -.
DR   STRING; Q05397; -.
DR   PhosphoSite; Q05397; -.
DR   PRIDE; Q05397; -.
DR   Ensembl; ENST00000340930; ENSP00000341189; ENSG00000169398.
DR   Ensembl; ENST00000395223; ENSP00000378649; ENSG00000169398.
DR   GeneID; 5747; -.
DR   KEGG; hsa:5747; -.
DR   UCSC; uc003yvt.1; human.
DR   CTD; 5747; -.
DR   GeneCards; GC08M141737; -.
DR   H-InvDB; HIX0020601; -.
DR   HGNC; HGNC:9611; PTK2.
DR   HPA; CAB004036; -.
DR   HPA; HPA001842; -.
DR   HPA; HPA029671; -.
DR   MIM; 600758; gene.
DR   PharmGKB; PA33955; -.
DR   eggNOG; prNOG18315; -.
DR   HOVERGEN; HBG004018; -.
DR   InParanoid; Q05397; -.
DR   PhylomeDB; Q05397; -.
DR   BRENDA; 2.7.10.2; 247.
DR   Pathway_Interaction_DB; angiopoietinreceptor_pathway; Angiopoietin receptor Tie2-mediated signaling.
DR   Pathway_Interaction_DB; caspase_pathway; Caspase cascade in apoptosis.
DR   Pathway_Interaction_DB; epha2_fwdpathway; EPHA2 forward signaling.
DR   Pathway_Interaction_DB; ephbfwdpathway; EPHB forward signaling.
DR   Pathway_Interaction_DB; fcer1pathway; Fc-epsilon receptor I signaling in mast cells.
DR   Pathway_Interaction_DB; igf1_pathway; IGF1 pathway.
DR   Pathway_Interaction_DB; avb3_integrin_pathway; Integrins in angiogenesis.
DR   Pathway_Interaction_DB; lysophospholipid_pathway; LPA receptor mediated events.
DR   Pathway_Interaction_DB; a4b1_paxindep_pathway; Paxillin-independent events mediated by a4b1 and a4b7.
DR   Pathway_Interaction_DB; met_pathway; Signaling events activated by Hepatocyte Growth Factor Receptor (c-Met).
DR   Pathway_Interaction_DB; vegfr1_2_pathway; Signaling events mediated by VEGFR1 and VEGFR2.
DR   Pathway_Interaction_DB; ret_pathway; Signaling events regulated by Ret tyrosine kinase.
DR   Pathway_Interaction_DB; syndecan_4_pathway; Syndecan-4-mediated signaling events.
DR   Reactome; REACT_13552; Integrin cell surface interactions.
DR   Reactome; REACT_18266; Axon guidance.
DR   Reactome; REACT_578; Apoptosis.
DR   Reactome; REACT_604; Hemostasis.
DR   NextBio; 22380; -.
DR   PMAP-CutDB; Q05397; -.
DR   ArrayExpress; Q05397; -.
DR   Bgee; Q05397; -.
DR   CleanEx; HS_PTK2; -.
DR   Genevestigator; Q05397; -.
DR   GermOnline; ENSG00000169398; Homo sapiens.
DR   GO; GO:0005856; C:cytoskeleton; TAS:ProtInc.
DR   GO; GO:0005829; C:cytosol; EXP:Reactome.
DR   GO; GO:0005925; C:focal adhesion; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004715; F:non-membrane spanning protein tyrosine kina...; IEA:EC.
DR   GO; GO:0042169; F:SH2 domain binding; IPI:UniProtKB.
DR   GO; GO:0004871; F:signal transducer activity; IEA:InterPro.
DR   GO; GO:0007229; P:integrin-mediated signaling pathway; TAS:ProtInc.
DR   GO; GO:0007172; P:signal complex assembly; IEA:InterPro.
DR   InterPro; IPR019749; Band_41_domain.
DR   InterPro; IPR014352; FERM/acyl-CoA-bd_prot_3-hlx.
DR   InterPro; IPR019748; FERM_central.
DR   InterPro; IPR000299; FERM_domain.
DR   InterPro; IPR005189; Focal_adhesion_kin_target_dom.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_cat_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR001245; Ser-Thr/Tyr-Pkinase.
DR   InterPro; IPR020773; Tyr_kinase_non-rcpt_FADK.
DR   InterPro; IPR020635; Tyr_Pkinase_cat_dom.
DR   InterPro; IPR020685; Tyr_prot_kinase.
DR   InterPro; IPR008266; Tyr_prot_kinase_AS.
DR   Gene3D; G3DSA:1.20.80.10; ACBP; 1.
DR   PANTHER; PTHR23256:SF277; Tyr_kinase_non-rcpt_FADK; 1.
DR   PANTHER; PTHR23256; Tyr_prot_kinase; 1.
DR   Pfam; PF00373; FERM_M; 1.
DR   Pfam; PF03623; Focal_AT; 1.
DR   Pfam; PF07714; Pkinase_Tyr; 1.
DR   PRINTS; PR00109; TYRKINASE.
DR   ProDom; PD006413; Focal_adhesion_target_reg; 1.
DR   SMART; SM00295; B41; 1.
DR   SMART; SM00219; TyrKc; 1.
DR   SUPFAM; SSF47031; FERM_3-hlx; 1.
DR   SUPFAM; SSF68993; Focal_AT; 1.
DR   SUPFAM; SSF56112; Kinase_like; 1.
DR   PROSITE; PS00660; FERM_1; FALSE_NEG.
DR   PROSITE; PS00661; FERM_2; 1.
DR   PROSITE; PS50057; FERM_3; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00109; PROTEIN_KINASE_TYR; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Acetylation; Alternative splicing; ATP-binding;
KW   Cell junction; Cell membrane; Complete proteome;
KW   Direct protein sequencing; Kinase; Membrane; Nucleotide-binding;
KW   Phosphoprotein; Polymorphism; Transferase; Tyrosine-protein kinase.
FT   INIT_MET      1      1       Removed.
FT   CHAIN         2   1052       Focal adhesion kinase 1.
FT                                /FTId=PRO_0000088077.
FT   DOMAIN       35    355       FERM.
FT   DOMAIN      422    680       Protein kinase.
FT   NP_BIND     428    436       ATP (By similarity).
FT   REGION      707   1052       Interaction with TGFB1I1.
FT   REGION      912   1052       Interaction with RGNEF (By similarity).
FT   COMPBIAS    712    733       Pro-rich.
FT   COMPBIAS    863    913       Pro-rich.
FT   ACT_SITE    546    546       Proton acceptor (By similarity).
FT   BINDING     454    454       ATP (By similarity).
FT   MOD_RES       2      2       N-acetylalanine.
FT   MOD_RES       5      5       Phosphotyrosine.
FT   MOD_RES      13     13       Phosphothreonine.
FT   MOD_RES      16     16       Phosphoserine.
FT   MOD_RES      29     29       Phosphoserine.
FT   MOD_RES     386    386       Phosphothreonine.
FT   MOD_RES     390    390       Phosphoserine.
FT   MOD_RES     392    392       Phosphoserine.
FT   MOD_RES     394    394       Phosphothreonine.
FT   MOD_RES     397    397       Phosphotyrosine.
FT   MOD_RES     406    406       Phosphothreonine.
FT   MOD_RES     407    407       Phosphotyrosine.
FT   MOD_RES     568    568       Phosphoserine.
FT   MOD_RES     570    570       Phosphotyrosine.
FT   MOD_RES     575    575       Phosphothreonine.
FT   MOD_RES     576    576       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     577    577       Phosphotyrosine; by autocatalysis.
FT   MOD_RES     580    580       Phosphoserine.
FT   MOD_RES     677    677       Phosphoserine.
FT   MOD_RES     700    700       Phosphothreonine.
FT   MOD_RES     702    702       Phosphoserine.
FT   MOD_RES     705    705       Phosphoserine.
FT   MOD_RES     708    708       Phosphoserine.
FT   MOD_RES     716    716       Phosphoserine.
FT   MOD_RES     720    720       Phosphotyrosine.
FT   MOD_RES     722    722       Phosphoserine.
FT   MOD_RES     840    840       Phosphoserine.
FT   MOD_RES     843    843       Phosphoserine.
FT   MOD_RES     861    861       Phosphotyrosine.
FT   MOD_RES     887    887       Phosphoserine.
FT   MOD_RES     910    910       Phosphoserine.
FT   MOD_RES     925    925       Phosphotyrosine.
FT   VAR_SEQ       1    181       Missing (in isoform 2, isoform 3 and
FT                                isoform 4).
FT                                /FTId=VSP_004967.
FT   VAR_SEQ     182    189       EMRGNALE -> MSDYWVVG (in isoform 2,
FT                                isoform 3 and isoform 4).
FT                                /FTId=VSP_004968.
FT   VAR_SEQ     472    472       A -> ACHYTSLHWNWCRYISDPNVDACPDPRNAE (in
FT                                isoform 2, isoform 3 and isoform 4).
FT                                /FTId=VSP_004969.
FT   VAR_SEQ     579    583       ASKGK -> GKKSG (in isoform 4).
FT                                /FTId=VSP_004971.
FT   VAR_SEQ     584   1052       Missing (in isoform 4).
FT                                /FTId=VSP_004972.
FT   VAR_SEQ     677    706       STILEEEKAQQEERMRMESRRQATVSWDSG -> FQNPAQM
FT                                LPASGRLPNQPCPERENYSFATF (in isoform 3).
FT                                /FTId=VSP_004973.
FT   VAR_SEQ     707   1052       Missing (in isoform 3).
FT                                /FTId=VSP_004974.
FT   VAR_SEQ     834    854       Missing (in isoform 2).
FT                                /FTId=VSP_004970.
FT   VARIANT     292    292       H -> P.
FT                                /FTId=VAR_041682.
FT   VARIANT     292    292       H -> Q.
FT                                /FTId=VAR_041683.
FT   VARIANT     793    793       V -> A (in a glioblastoma multiforme
FT                                sample; somatic mutation).
FT                                /FTId=VAR_041684.
FT   VARIANT    1030   1030       D -> E.
FT                                /FTId=VAR_041685.
FT   VARIANT    1044   1044       K -> E (in a metastatic melanoma sample;
FT                                somatic mutation).
FT                                /FTId=VAR_041686.
FT   MUTAGEN     928    928       V->G: Loss of interaction with TGFB1I1.
FT   MUTAGEN    1034   1034       L->S: Loss of interaction with TGFB1I1.
FT   CONFLICT    778    778       P -> S (in Ref. 2; AAA35819).
FT   HELIX       419    421
FT   STRAND      422    430
FT   STRAND      432    441
FT   STRAND      449    455
FT   TURN        457    460
FT   HELIX       462    476
FT   STRAND      486    490
FT   STRAND      492    494
FT   STRAND      496    500
FT   HELIX       507    513
FT   TURN        514    517
FT   HELIX       520    539
FT   HELIX       549    551
FT   STRAND      552    556
FT   STRAND      559    562
FT   HELIX       586    588
FT   HELIX       591    596
FT   HELIX       601    616
FT   TURN        622    625
FT   HELIX       628    630
FT   HELIX       631    636
FT   HELIX       649    658
FT   HELIX       663    665
FT   HELIX       669    685
FT   STRAND      915    917
FT   HELIX       923    942
FT   HELIX       947    949
FT   HELIX       950    971
FT   HELIX       972    974
FT   HELIX       977    979
FT   HELIX       980   1006
FT   TURN       1007   1009
FT   STRAND     1010   1012
FT   HELIX      1013   1045
SQ   SEQUENCE   1052 AA;  119233 MW;  D8A4C15138AB0243 CRC64;
     MAAAYLDPNL NHTPNSSTKT HLGTGMERSP GAMERVLKVF HYFESNSEPT TWASIIRHGD
     ATDVRGIIQK IVDSHKVKHV ACYGFRLSHL RSEEVHWLHV DMGVSSVREK YELAHPPEEW
     KYELRIRYLP KGFLNQFTED KPTLNFFYQQ VKSDYMLEIA DQVDQEIALK LGCLEIRRSY
     WEMRGNALEK KSNYEVLEKD VGLKRFFPKS LLDSVKAKTL RKLIQQTFRQ FANLNREESI
     LKFFEILSPV YRFDKECFKC ALGSSWIISV ELAIGPEEGI SYLTDKGCNP THLADFTQVQ
     TIQYSNSEDK DRKGMLQLKI AGAPEPLTVT APSLTIAENM ADLIDGYCRL VNGTSQSFII
     RPQKEGERAL PSIPKLANSE KQGMRTHAVS VSETDDYAEI IDEEDTYTMP STRDYEIQRE
     RIELGRCIGE GQFGDVHQGI YMSPENPALA VAIKTCKNCT SDSVREKFLQ EALTMRQFDH
     PHIVKLIGVI TENPVWIIME LCTLGELRSF LQVRKYSLDL ASLILYAYQL STALAYLESK
     RFVHRDIAAR NVLVSSNDCV KLGDFGLSRY MEDSTYYKAS KGKLPIKWMA PESINFRRFT
     SASDVWMFGV CMWEILMHGV KPFQGVKNND VIGRIENGER LPMPPNCPPT LYSLMTKCWA
     YDPSRRPRFT ELKAQLSTIL EEEKAQQEER MRMESRRQAT VSWDSGGSDE APPKPSRPGY
     PSPRSSEGFY PSPQHMVQTN HYQVSGYPGS HGITAMAGSI YPGQASLLDQ TDSWNHRPQE
     IAMWQPNVED STVLDLRGIG QVLPTHLMEE RLIRQQQEME EDQRWLEKEE RFLKPDVRLS
     RGSIDREDGS LQGPIGNQHI YQPVGKPDPA APPKKPPRPG APGHLGSLAS LSSPADSYNE
     GVKLQPQEIS PPPTANLDRS NDKVYENVTG LVKAVIEMSS KIQPAPPEEY VPMVKEVGLA
     LRTLLATVDE TIPLLPASTH REIEMAQKLL NSDLGELINK MKLAQQYVMT SLQQEYKKQM
     LTAAHALAVD AKNLLDVIDQ ARLKMLGQTR PH
//
